Home LiteratureArticle Details
PMID: 5015032 Published · ppublish English Journal Article

Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

British journal of pharmacology ·Vol. 44 ·No. 1 ·1972-01-00 ·Pages 117-39

Born GV, Juengjaroen K, Michal F

Abstract

1. The specificity of platelet receptor sites for 5-HT uptake and for the rapid morphological change and aggregation was investigated with 5-hydroxy-tryptamine (5-HT) and seventeen analogues as well as with some antagonists of 5-HT.2. The analogues, with the exception of 5-hydroxy-N'N'-dibutyltryptamine, caused the rapid morphological change in platelets. In concentrations below those needed to produce the agonistic action (viz. 0.05-2.0 muM), these analogues themselves inhibited competitively the shape change caused by 5-HT.3. The velocity of change in shape caused by 5-HT was reduced in low Na media.4. Ten analogues produced platelet aggregation; three of these, viz. 5-methoxy-alpha-methyltryptamine, 5-hydroxy-alpha-methyltryptamine and 5-hydroxy-N'N'-diisopropyltryptamine), were approximately equipotent with 5-HT. Six analogues did not induce platelet aggregation.5. All the analogues which prevented the initial change in shape of platelets caused by 5-HT also inhibited its aggregating effect, apparently competitively with low K(i) values (0.02-1.6 muM).6. As with the inhibition of shape change, the inhibition of aggregation shows relatively low structural specificity of the receptor site.7. Methysergide was a potent inhibitor of shape change and aggregation (K(i) approximately 0.03 muM); imipramine was much less inhibitory (K(i) approximately 5-10 muM).8. Only one analogue (5-hydroxy-alpha-methyltryptamine) was taken up like 5-HT by platelets. All the other analogues inhibited the uptake of 5-HT by platelets (K(i)=0.2-2.7 muM).9. Methysergide was a weak inhibitor of 5-HT uptake (K(i) approximately 125 muM) whereas imipramine was very effective (K(i) approximately 0.3 muM).10. Our results show that the initial change in shape of platelets is required for and precedes aggregation. The structural specificity of the platelet receptor concerned with shape change and aggregation caused by 5-HT appears low whereas the uptake mechanism is a highly specific one. The uptake probably proceeds through more than one step, the relationship between the steps is not yet clear.

MeSH Terms
Blood Coagulation/drug effects Blood Platelets/drug effects,metabolism Female Fluorometry Humans Imipramine/pharmacology Male Methysergide/pharmacology Muscle, Smooth/drug effects Serotonin/metabolism,pharmacology Sodium Tryptamines/pharmacology
Chemicals
Tryptamines Serotonin Sodium Imipramine Methysergide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Born G V
Juengjaroen K
Michal F
References (31)
31 references, click to expand
  1. Uptake, metabolism and release of (3H)-adrenaline by human platelets.
    Br J Pharmacol. 1970 Aug;39(4):765-78 PMID: 5485150
  2. Platelet aggregation in mammalians (human, rat, rabbit, guinea-pig, horse, dog). A comparative study.
    Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):99-111 PMID: 4869432
  3. Sodium-dependent accumulation of 5-hydroxytryptamine by rat blood platelets.
    Br J Pharmacol. 1969 Nov;37(3):680-8 PMID: 5348470
  4. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.
    Br J Pharmacol Chemother. 1968 Jan;32(1):1-16 PMID: 4870578
  5. PLATELET CLUMPING IN VITRO.
    Br J Haematol. 1964 Jan;10:78-93 PMID: 14115594
  6. A sensitive method for the assay of 5-hydroxytryptamine.
    Br J Pharmacol Chemother. 1957 Sep;12(3):344-9 PMID: 13460242
  7. Inhibition of serotonin-induced platelet aggregation in relation to thrombus production.
    J Pharmacol Exp Ther. 1969 Apr;166(2):276-84 PMID: 5776985
  8. Changes in the distribution of phosphorus in platelet-rich plasma during clotting.
    Biochem J. 1958 Apr;68(4):695-704 PMID: 13522683
  9. D-receptor for serotonin on blood platelets.
    Nature. 1969 Mar 29;221(5187):1253-4 PMID: 5773843
  10. THE INITIAL CHANGES IN PLATELET MORPHOLOGY FOLLOWING THE ADDITION OF ADENOSINE DIPHOSPHATE.
    J Atheroscler Res. 1965 Jul-Aug;5(4):440-4 PMID: 14321357
  11. Effects of 5-hydroxytryptamine on platelet aggregation.
    Nature. 1968 Apr 13;218(5137):137-41 PMID: 5645287
  12. Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma.
    Nat New Biol. 1971 Jun 16;231(24):220-2 PMID: 5282675
  13. The mechanism of serotonin and catecholamine uptake by platelets.
    J Pharmacol Exp Ther. 1959 Oct;127:96-102 PMID: 14403856
  14. The fate of 5-hydroxytryptamine in a smooth muscle and in connective tissue.
    J Physiol. 1962 Apr;161:160-74 PMID: 13871376
  15. Source of 'serotonin' in serum.
    Nature. 1951 Sep 1;168(4270):385 PMID: 14875097
  16. Aggregation of blood platelets by adenosine diphosphate and its reversal.
    Nature. 1962 Jun 9;194:927-9 PMID: 13871375
  17. Two kinds of tryptamine receptor.
    Br J Pharmacol Chemother. 1957 Sep;12(3):323-8 PMID: 13460238
  18. The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets.
    Br J Pharmacol Chemother. 1958 Mar;13(1):62-4 PMID: 13523136
  19. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
    J Physiol. 1969 Apr;201(2):409-23 PMID: 5780550
  20. Spectrophotofluorometric assay in the visible and ultraviolet.
    Science. 1955 Jul 1;122(3157):32-3 PMID: 14385815
  21. 5-Hydroxytryptamine in normal human platelets.
    J Physiol. 1955 Dec 29;130(3):711-20 PMID: 13278930
  22. The uptake of 5-hydroxytryptamine by blood platelets in the cold.
    J Physiol. 1959 Jun 23;147(1):153-61 PMID: 13673393
  23. Observations on the change in shape of blood platelets brought about by adenosine diphosphate.
    J Physiol. 1970 Aug;209(2):487-511 PMID: 5499539
  24. Factors influencing platelet function: adhesion, release, and aggregation.
    Pharmacol Rev. 1970 Jun;22(2):97-187 PMID: 4192958
  25. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.
    J Physiol. 1969 Apr;201(2):397-408 PMID: 5780549
  26. An easy method to determine the serotonin content of human platelets.
    J Clin Pathol. 1962 Mar;15:191-3 PMID: 13882404
  27. The estimation of 5-hydroxytryptamine (serotonin) in biological tissues.
    J Biol Chem. 1955 Jul;215(1):337-44 PMID: 14392167
  28. Studies on the uptake of 5-hydroxytryptamine by blood platelets.
    J Physiol. 1959 Jun 11;146(3):472-91 PMID: 13665673
  29. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes.
    Br J Pharmacol. 1968 Nov;34(3):591-7 PMID: 5726788
  30. Transfer and storage of biogenic monoamines in subcellular organelles of blood platelets.
    Prog Brain Res. 1969;31:47-52 PMID: 5345802
  31. The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation.
    Br J Pharmacol Chemother. 1959 Mar;14(1):87-98 PMID: 13651584
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1972-01-00
Pages
117-39
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1665693
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com